© 2026 PMGuru Studio. Original research. Source: studio.pmguru.org. Contact info@pmguru.org. Quote findings only with the name PMGuru Studio and a link to this page. Do not republish this report, its charts, or its scoreboard as your own.
PMGuru Studio · Original research · 2027
© 2026 PMGuru Studio
100 websites · 8 dimensions · 4-5 September 2026
Medspa Website Conversion Benchmark 2027
Bottom line
A booking path is common. Proof at the action is not.
The review found a median Website Conversion Readiness Score of 41.5 across 100 public U.S. medspa websites. Most medspa websites do not fail because they lack a way to inquire. They fail when patients have to assemble the decision for themselves.
- Median score
- 41.5
- Proof at the action
- 20
- Clear next step
- 80%
- CTA before first scroll
- 47%
Range 7 to 64
Weakest dimension
Booking path exists
First mobile view
© 2026 PMGuru Studio. Original research. Cite this page. Do not republish as your own. You may quote findings if you name PMGuru Studio and link to this benchmark. You may not republish this report, its charts, or its scoreboard as your own research, white paper, blog, or sales leave-behind.
How to use this research
01
Read the snapshot
Four numbers. Then the scoreboard. That is the sample in one view.
02
Use the operator notes
Each insight names the gap, the owner, and the cost of waiting.
03
Ship four moves
Proof, candidacy, first-view CTA, cost orientation. This week, not a redesign.
Findings
What the sample shows
The weakest dimension is proof near conversion points (median 20). The strongest is mobile booking visibility (median 67).
Proof near conversion points
Weaker
20
Pricing cues
Weaker
33
Provider credibility
Weaker
33
Treatment-page intent match
Mixed
42
Inquiry-to-booking mechanics
Mixed
46
Local-search path quality
Mixed
50
Form friction
Mixed
63
Mobile booking visibility
Stronger
67
Figure 1. Median Website Conversion Readiness by dimension, lowest first. Bars show median. The muted band is the interquartile range. Weight is in the dimension notes below. Source: PMGuru Studio.
Score bands. Weaker: median under 34. Mixed: 34 to 66. Stronger: 67 and up. Bands describe website scores in this sample, not appointment conversion.
Score distribution
- Min
- 7
- Bottom 25%
- 30.8
- Median
- 41.5
- Top 25%
- 49
- Max
- 64
Figure 2. Overall scores in the locked sample. Middle half of sites sit between 30.8 and 49. No site scored above 64. Source: PMGuru Studio.
| Dimension | Q1 | Median | Q3 | Weight |
|---|---|---|---|---|
| Mobile booking visibility | 53 | 67 | 73 | 14% |
| Treatment-page intent match | 28 | 42 | 54 | 20% |
| Proof near conversion points | 0 | 20 | 28.5 | 18% |
| Form friction | 63 | 63 | 67 | 8% |
| Pricing cues | 0 | 33 | 50 | 5% |
| Provider credibility | 0 | 33 | 44 | 10% |
| Local-search path quality | 31.8 | 50 | 61 | 7% |
| Inquiry-to-booking mechanics | 29 | 46 | 54 | 18% |
Key statistics
Scan the numbers first. Source sits once under the grid, not under every cell.
47%
of reviewed medspa websites expose a consultation or booking CTA before the first mobile scroll.
80%
make the next step unambiguous rather than sending patients to a generic contact path.
39%
place readable reviews next to a booking or consultation action.
38%
connect a named provider from a treatment page.
62%
give any usable financial orientation before asking the patient to inquire.
1
median required fields on the primary inquiry form (0 when the primary path is phone or SMS).
18%
give usable candidacy information on a treatment page.
65%
have a dedicated treatment URL rather than only a services list.
Figure 3. Counted shares from the locked sample. Source: PMGuru Studio, Medspa Website Conversion Benchmark 2027. Sample: n=100 public U.S. medspa websites. Review period: 4-5 September 2026.
Where sites are thin
Share of reviewed sites scoring 2 or 3 on each signal, unless the row is an absence count.
- SMS path8%
- No CTA in the first mobile view10%
- Provider proof next to the CTA10%
- Range or starting price15%
- No dedicated treatment URL16%
- Named provider at an adequate level16%
- Usable candidacy information18%
- Treatment-page FAQ28%
- Before-and-after next to the CTA31%
- Consultation request path37%
- Provider linked from the treatment page38%
- Reviews next to the CTA39%
- Financing information43%
- On-site NAP consistency46%
- CTA usable in the first mobile view47%
- Downtime or recovery information47%
- Directions on the site52%
- Any usable financial orientation62%
- Dedicated treatment page65%
- Direct booking path in the capture65%
- Scheduler present in the capture65%
- Persistent or repeating mobile CTA70%
- Phone path72%
- CTA names a real next step73%
- Unambiguous next step80%
Figure 4. Share of sites scoring 2 or 3, lowest first. Coral marks signals under 34%. Absence rows are labeled as such. Source: PMGuru Studio.
Who is in the sample
Nationwide convenience sample. One brand equals one domain. Medians describe this sample, not every U.S. medspa.
Census region
- Northeast23 · 47
- Midwest21 · 35
- South31 · 40
- West25 · 42
Ownership
- Independent86 · 41.5
- Chain14 · 41.5
Locations
- Single location58 · 40.5
- Multi-location42 · 42.5
Booking model in capture
- Direct booking43 · 45
- Mixed32 · 46
- Consult-only9 · 37
- Unclear in capture16 · 18
What higher-scoring sites do differently
Sites in the top quartile were more likely to show provider proof on treatment pages (28% vs 4%).
Top quartile
28%
Rest of sample
4%
Sites in the top quartile were more likely to show a specific next-step CTA (100% vs 64%).
Top quartile
100%
Rest of sample
64%
Sites in the top quartile were more likely to show an unambiguous next step (100% vs 73.3%).
Top quartile
100%
Rest of sample
73.3%
Sites in the top quartile were more likely to show a provider link from the treatment page (84% vs 22.7%).
Top quartile
84%
Rest of sample
22.7%
Sites in the top quartile were more likely to show a persistent mobile CTA (100% vs 60%).
Top quartile
100%
Rest of sample
60%
Figure 5. Association only. A 15-point gap is required to appear here. This is not a causal claim about bookings. Source: PMGuru Studio.
Insights
What I would change first
Operator judgment on counted patterns. These notes do not claim that a website pattern causes bookings, revenue, or clinical outcomes.
Note 01
The booking button is not the leak
The review found 80% of sites make the next step unambiguous. Median proof-near-conversion is 20. Median form friction is 63, and the median inquiry asks for 1 required field. I would not spend the week shortening a form that already asks for one field while the treatment page asks for a consult with no proof beside the CTA.
Owner. Whoever owns the money treatment URL, usually the founder or the marketing lead.
If you wait. Patients can inquire before they can decide. That produces tire-kickers and silent exits, not a cleaner calendar.
Note 02
Treatment pages exist. Decision answers often do not.
65% of reviewed sites have a dedicated treatment URL. 18% give usable candidacy information. 47% cover downtime. 28% include a real FAQ. The page is there. The questions a searching patient needs before they book are often not.
Owner. Clinical and marketing together. Candidacy is a medical judgment framed in plain language, not a slogan.
If you wait. A thin treatment page trains the patient to leave for a competitor who answers downtime, aftercare, and who it is for.
Note 03
First-view CTA is still a coin flip
47% of sites expose a usable consultation or booking CTA before the first mobile scroll. 10% show none in that first view. I would fix the 390px first view before I commissioned a new homepage film.
Owner. The person who can change the header and sticky bar without a six-week ticket.
If you wait. Treatment interest that arrives from search dies in the first viewport when the next step is hidden in a menu.
Note 04
Proof lives on About. The action lives on the treatment page.
39% place readable reviews next to a booking or consultation action. 10% put provider proof at that action. 38% connect a named provider from the treatment page. Trust is collected. It is not placed where the patient is asked to act.
Owner. The operator who can move existing reviews and a provider name onto the treatment URL this week.
If you wait. A consult request without nearby proof is a colder lead. The site paid for the click and then made the patient assemble credibility themselves.
Note 05
Chain and independent sites landed on the same median
Independent sites (n=86) had a median Website Conversion Readiness Score of 41.5. Chain sites (n=14) had a median of 41.5. Ownership type did not separate conversion readiness in this sample. 8% offer SMS. Channel completeness is thin even where a book button exists.
Owner. Do not blame the brand structure. Assign the path: treatment URL, proof at CTA, first-view action.
If you wait. A national logo does not fix a broken decision path. A single-location studio with proof at the CTA can outscore a chain brochure.
Note 06
Region describes this sample. It is not the operating diagnosis.
In this sample, Northeast median was 47 and Midwest median was 35. That describes the reviewed websites, not the U.S. industry. I would not use region as the fix. I would use proof placement and treatment-page answers.
Owner. The operator reading this report, not a census region.
If you wait. Chasing a market narrative wastes a week. Moving reviews and candidacy onto the money URL can ship this week.
What to change this week
Four operating moves that match the weakest patterns. Do not start with a full redesign.
Move 01
Put reviews and a named provider next to the treatment-page CTA.
Owner. Founder or marketing lead, this week.
39% of reviewed sites already do the review half. Median proof-near-conversion is 20. Move existing proof. Do not wait for a new photoshoot.
Move 02
Add candidacy, downtime, and one FAQ to the primary treatment URL.
Owner. Provider plus copy owner, on the money page only.
18% of sites give usable candidacy information. A searching patient will not assemble that from a services grid.
Move 03
Name the next step in the first mobile view: Book a consult, Call, or Text.
Owner. Whoever can edit the header without a redesign ticket.
47% of sites already expose that action before the first scroll. Hide it in a menu and the search click is wasted.
Move 04
If you will not publish prices, put a starting range or a "consult explains cost" line at the action.
Owner. Operator who sets pricing policy.
15% of reviewed sites show a range or starting price. Financial silence at the CTA sends the patient to guess, then leave.
What we measure
Eight conversion dimensions
50 scored signals, grouped so reviewers are not rewarding the same behavior twice. Form friction is the cost of completing a request. Inquiry-to-booking is whether a real next step exists.
01
Mobile booking visibility
StrongerWhether a phone-sized first view makes the next step obvious and keeps that path available as the patient scrolls.
Median 67. 47% of reviewed sites expose a usable consultation or booking CTA before the first mobile scroll. 10% show none in that first view. Persistence is stronger: 70% keep an action available after scroll.
02
Treatment-page intent match
MixedWhether a dedicated treatment page answers the questions a searching patient needs before requesting a consult. Length is not a virtue.
Median 42. 65% have a dedicated treatment URL. 18% give usable candidacy information. 47% cover downtime. 28% include a real FAQ. Pages exist. Decision answers often do not.
03
Proof near conversion points
WeakerWhether trust evidence appears where the patient is asked to act. Proof that lives only on About or a Reviews page scores lower.
Median 20. This is the weakest dimension in the sample. 39% place readable reviews next to a booking or consultation action. 31% place before-and-after proof there. 10% put provider proof at the action.
Provider credibility scores whether named, credentialed providers exist. This dimension scores whether proof is placed at the decision.
04
Form friction
MixedHow painful the primary inquiry mechanism is once the patient starts it. 3 is a low-friction consult request. 0 is unusable. Phone-only can score well if tap-to-call is clear.
Median 63. This is among the strongest dimensions. Median required fields on the primary inquiry is 1. The form is rarely the conversion leak in this sample.
Inquiry-to-booking scores which next steps exist and whether they are clear. Form friction scores the cost of completing the primary request.
05
Pricing cues
WeakerWhether the site gives enough economic context to take the next step. Public price lists are not automatically better than a clear “pricing depends on a consult” explanation.
Median 33. 62% give some usable financial orientation. 15% show a range or starting price. 43% mention financing. Sites mention cost more often than they name a number.
06
Provider credibility
WeakerWhether the public site identifies real providers with verifiable-looking credentials. Prestige adjectives without names do not score well.
Median 33. 16% present a named provider at an adequate level. 38% connect that provider from a treatment page. The bio often lives on About, not on the page that asks for the consult.
Proof near conversion scores placement. This dimension scores whether the underlying provider evidence exists.
07
Local-search path quality
MixedWhether the site supports a local search journey with consistent identity, location context, and a local booking path. Location-page spam is not rewarded.
Median 50. 46% show adequate NAP consistency on the site. 52% include usable directions. This is not a Google Business Profile audit.
08
Inquiry-to-booking mechanics
MixedWhat happens after intent: whether the site offers a clear next step (book, consult, call, text, scheduler) instead of an ambiguous Contact Us dead end.
Median 46. 80% make the next step unambiguous. 65% offer a direct booking path in the capture. 72% offer phone. 8% offer SMS. Channel completeness is thinner than "there is a way to inquire."
Form friction scores how hard the form is. This dimension scores whether a real next step exists and is unambiguous.
Patient decision path
Search to booking
Median scores at each stage of the path the study scores against. Proof is the break.
01 · Search
50
Mixed
Local identity and treatment relevance on the public site.
02 · Maps
1.7
Weaker
On-site NAP, directions, and local booking path. Not a Google Business Profile audit.
03 · Treatment page
42
Mixed
Whether the treatment URL answers decision questions.
04 · Proof
20
Weaker
Trust evidence placed at the action, not only on About.
05 · Consultation
63
Mixed
Cost of completing the primary inquiry. Higher is lower friction.
06 · Booking
46
Mixed
Clarity of book, consult, call, text, and scheduler paths.
Scoring
A 0-3 rubric, then a 0-100 score
Reviewers do not invent a proprietary mystery number. Each criterion has written examples for 0, 1, 2, and 3.
- 0 Absent
- The pattern is not there in any usable form.
- 1 Weak
- It exists but is vague, buried, or easy to miss.
- 2 Adequate
- A patient can use it without hunting.
- 3 Strong
- It is specific, well placed, and stays usable as the patient moves.
Weights
| Dimension | Weight |
|---|---|
| Treatment-page intent match | 20% |
| Proof near conversion points | 18% |
| Inquiry-to-booking mechanics | 18% |
| Mobile booking visibility | 14% |
| Provider credibility | 10% |
| Form friction | 8% |
| Local-search path quality | 7% |
| Pricing cues | 5% |
Each criterion is scored 0 (absent), 1 (weak), 2 (adequate), or 3 (strong). A dimension score is the sum of its criterion scores divided by the maximum possible sum, then scaled to 0-100 and rounded to the nearest integer. The Website Conversion Readiness Score is a weighted sum of the eight dimension scores. Weights: treatment-page intent match 20%, proof near conversion 18%, inquiry-to-booking 18%, mobile booking visibility 14%, provider credibility 10%, form friction 8%, local-search path 7%, pricing cues 5%. Form friction uses the same 0-3 scale, where 3 means low friction.
What a high score means
The score measures the presence and quality of website patterns that reduce friction and support patient decision-making. It does not measure actual appointment conversion, revenue, or clinical quality.
A high score does not mean better clinical care, higher revenue, higher actual appointment conversion, medical superiority, or better patient outcomes.
Appendix
Methodology
How the study is built
Objective
Measure whether public medspa websites help a prospective patient move from treatment interest to an appropriate next step. The unit of observation is the public website, not the practice P&L.
Sample
The 2027 study evaluates 100 public U.S. medspa websites across eight conversion dimensions and 50 scored signals. One brand equals one website. Multi-location groups are counted once.
The locked sample is a nationwide convenience sample of highly visible public U.S. medspa websites spanning all four Census regions: Northeast, Midwest, South, and West. Markets include New York, Boston, Philadelphia, Chicago, Columbus, Cleveland, Indianapolis, Kansas City, Minneapolis, St. Louis, Atlanta, Miami, Tampa, Orlando, Houston, Dallas, Austin, Nashville, Charlotte, Washington D.C., Oklahoma City, Los Angeles, San Diego, the San Francisco Bay Area, Denver, Seattle, Portland, Phoenix, Tucson, and other competitive metros. This is not a probability sample of every U.S. medspa. Findings describe the reviewed websites, not the entire industry.
Inclusion
- Public-facing U.S. medspa or medical-aesthetic practice websites.
- Sites that offer consultative aesthetic treatments (for example neuromodulators, fillers, lasers, medical-grade facials, body treatments) as a primary or major service.
- Independent practices and multi-location groups are both included. The locked sample mixes single-location studios with national and regional chains.
- Only publicly observable pages and signals are scored. No private analytics, ads accounts, or EHR access.
Exclusion
- Pure product ecommerce with no in-clinic consult path.
- Hospital or health-system dermatology departments that are not operating as medspas.
- Directory listings, marketplace profiles, or social profiles scored as if they were the practice website.
- Passworded patient portals, after-login booking, or any surface that is not publicly reviewable.
- Sites that exist only as coming-soon pages at the time of review.
Review period and devices
4-5 September 2026
Primary review used publicly fetched homepage HTML and, when a dedicated treatment URL was discoverable, that treatment page. Client-rendered booking widgets that did not appear in the captured document were scored as not publicly observable in that capture, not as proven absent on a fully rendered phone. Conservative 1-2 scores were used when a signal was ambiguous. Scores of 3 required a clear captured pattern such as a tel: path or specific book/consult language.
Reviewer process
- One reviewer scores a site against the published 0-3 rubric, with the definition visible for every criterion.
- Evidence notes are required for scores of 0 or 3.
- Machine-assisted HTML captures were accepted only after a human pass against the rubric. Assisted records in the locked file are marked reviewSource: assisted with needsVerification: false.
- Before publication, approximately 10-15% of sites should be independently rescored to find ambiguous criteria. This is a quality-control pass, not a published inter-rater statistic unless that statistic is actually calculated.
Limitations
- No Search Console, call tracking, or private conversion data.
- No claim that website patterns cause bookings, revenue, or clinical outcomes.
- Google Business Profile, ads, and review platforms are out of scope except where they appear on the website.
- Clinical quality, safety, and patient outcomes are not scored.
- A high score is not an endorsement. A low score is not a public ranking of named practices.
- JavaScript-heavy sites can under-report forms, sticky bars, and schedulers in a static HTML capture. That limitation is conservative: missing widgets were not invented.
Ethics
Conversion here means making it easier for an interested patient to understand, evaluate, and take an appropriate next step. The rubric does not reward fake scarcity, misleading reviews, manufactured urgency, unsupported clinical claims, hidden pricing traps, deceptive before-and-after presentation, or aggressive dark patterns.
The public report presents aggregated results. Individual practice names and scores stay internal unless PMGuru later publishes a fair, factual example with an observable public element. This study is not a “worst websites” ranking.
Earlier methodology: Medspa Website Benchmark 2026. That page locked sampling rules before this scored conversion framework.
Questions
Direct answers
Press
Using this research?
You may quote findings if you name PMGuru Studio and link to this benchmark. You may not republish this report, its charts, or its scoreboard as your own research, white paper, blog, or sales leave-behind.
PMGuru Studio. Medspa Website Conversion Benchmark 2027. https://studio.pmguru.org/research/medspa-website-conversion-benchmark/2027/
© 2026 PMGuru Studio. Original research. Cite this page. Do not republish as your own. Copying or cutting text from this page appends this citation and info@pmguru.org. Printing includes the same notice on every sheet.
A downloadable executive summary is not offered yet. The findings on this page are not gated.
Next step
Benchmark your medspa website
See how your website performs across the same patient-decision dimensions used in the 2027 benchmark.
Not a medspa website?
$10M-$100M healthcare companies need revenue leadership, not a five-page site
PMGuru Studio is for medspa websites that turn treatment searches into booked consults. If you run a growth-stage healthcare company with stalled revenue, product-sales misalignment, or PE pressure, that work lives on the consulting side.
Healthcare revenue leadershipCanonical research path /studio/research/medspa-website-conversion-benchmark/2027. The score measures the presence and quality of website patterns that reduce friction and support patient decision-making. It does not measure actual appointment conversion, revenue, or clinical quality.
PMGuru Studio original research · studio.pmguru.org · info@pmguru.org · Quote with name and link. Do not republish as your own.
PMGuru Studio original research · studio.pmguru.org · info@pmguru.org · Quote with name and link. Do not republish as your own.
